Cargando…
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature
INTRODUCTION: Rheumatoid arthritis is an autoimmune arthritis in which two inflammatory cytokines, tumor necrosis factor-α and interleukin-1β, play a critical role in the induction and progression of the disease. Several reports and data from registries have discussed the association between chronic...
Autores principales: | Ruscitti, Piero, Cipriani, Paola, Cantarini, Luca, Liakouli, Vasiliki, Vitale, Antonio, Carubbi, Francesco, Berardicurti, Onorina, Galeazzi, Mauro, Valenti, Marco, Giacomelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457168/ https://www.ncbi.nlm.nih.gov/pubmed/26033326 http://dx.doi.org/10.1186/s13256-015-0603-y |
Ejemplares similares
-
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities
por: Ruscitti, Piero, et al.
Publicado: (2018) -
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
por: Ruscitti, Piero, et al.
Publicado: (2017) -
Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
por: Ruscitti, Piero, et al.
Publicado: (2017) -
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study
por: Ruscitti, Piero, et al.
Publicado: (2019) -
The Role of IL-1β in the Bone Loss during Rheumatic Diseases
por: Ruscitti, Piero, et al.
Publicado: (2015)